30 July 2024
Notice of meeting and proxy form
Notice is hereby given that the 2024 Annual Shareholder Meeting of Blis Technologies Limited will be held on Wednesday 28 August 2024 at 11.00am in the Dunedin Public Art Gallery, Auditorium, 30 The Octagon, Dunedin and online at www.virtualmeeting.co.nz/blt24 (registrations will open at 10.30am).
Attached are the following documents which are being sent to shareholders today:
- Notice of Meeting
- Voting/Proxy Form
Ends
For further information, please contact:
Richard Wingham
Chief Financial Officer
Blis Technologies Limited
+64 21 284 0446
About Blis Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.
Website: www.blis.co.nz
Instagram: @blisprobiotics #blisk12 #blism18 #blisq24
Facebook: @BLISProbiotics
Trading was extended as 335.4 million shares worth $1.93 billion changed hands.
A soft NZ dollar and economic pressures had a notable impact, but the CEOs are optimistic.
The small-cap aged care services company's shares have lifted 57% this year.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details